SCHEMBL10691444

SCHEMBL10691444

CCCCCCC1(c2ccccc2OC)Cc2ccccc2N(C)C1=O

nearest known ligand 0.43

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.43
HTR7 P34969 5/20 0.41
HTR1A P08908 1/20 0.40
DRD2 P14416 3/20 0.39
DRD3 P35462 3/20 0.39
ADRA1D P25100 3/20 0.38
ADRA1A P35348 3/20 0.38
ADRA1B P35368 3/20 0.38
OPRL1 P41146 1/20 0.38
SCN9A Q15858 1/20 0.37
TDP1 Q9NUW8 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
ATM Q13315 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10690604 0.86 TDP1 (0.42) ALDH1A1HTR7DRD2DRD3ADRA1D
SCHEMBL10692777 0.86 OPRL1 (0.35) ALDH1A1HTR7HTR1ADRD2DRD3
SCHEMBL10694080 0.84 NPC1 (0.45) HTR7HTR1AOPRL1SCN9A
SCHEMBL10755079 0.81 HTR1A (0.40) ALDH1A1HTR7HTR1ADRD2DRD3
SCHEMBL10695992 0.81 SCN9A (0.39) ALDH1A1HTR7ADRA1DADRA1AADRA1B
Oxalic Acid SCHEMBL10688530 0.78 SMPD1 (0.45) ALDH1A1
Hydrochloric Acid SCHEMBL10688129 0.78 ALDH1A1 (0.38) ALDH1A1HTR7HTR1ADRD2DRD3
SCHEMBL10689170 0.75 ADRA1A (0.40) ALDH1A1DRD2DRD3ADRA1DADRA1A
SCHEMBL10691597 0.72 ADRA1A (0.39) ALDH1A1DRD2DRD3ADRA1DADRA1A
SCHEMBL10694392 0.69 NPC1 (0.47) ALDH1A1HTR7OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4778793-A CONTROLLING CALCIUM CONCENTRATION-CARDIOVASCULAR DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 1988-10-18 US disclosed
EP-0212216-A1 Dihydroquinolinone derivatives, processes for their preparation, medicaments containing them, the use of these medicaments, and intermediates for their preparation HOECHST AKTIENGESELLSCHAFT (DE) 1987-03-04 EP disclosed